Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05418153 · ClinicalTrials.gov registry record
Synergy Lens Outcomes Evaluation
A clinical trial of Presbyopia and Pseudophakia, sponsored by Center For Sight.
- Completed
- Registry status
- 52
- Enrollment target
- 2
- Study locations
NCT05418153 is a study of Presbyopia and Pseudophakia that has completed, run by Center For Sight. The registered enrollment target is 52 participants, below the 269-participant average among 38 other Presbyopia trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05418153, a study of Presbyopia and Pseudophakia, has completed, sponsored by Center For Sight.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a single visit study to evaluate the visual outcomes and patient satisfaction of patients who were bilaterally implanted with the Tecnis Synergy IOL between June 1 and December 31, 2021 in 2 centers in USA
Conditions Studied
Interventions
- DEVICE Tecnis Synergy IOL
Study Locations (2)
Florida
- Center For Sight - Venice
South Carolina
- Carolina Eyecare Physicians - Mt. Pleasant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2022-03-14 |
| Est. Completion | 2022-11-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05418153
The ClinicalTrials.gov registry entry for NCT05418153 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 269-participant average among 38 other Presbyopia trials with a reported enrollment target (81% lower). The listed sponsor is Center For Sight, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Presbyopia appearing as the primary indexed condition, and to 1 intervention - of which Tecnis Synergy IOL is the first listed.
NCT05418153 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, South Carolina.
Frequently Asked Questions
What is clinical trial NCT05418153 about?
NCT05418153 is a clinical study titled "Synergy Lens Outcomes Evaluation". This is a single visit study to evaluate the visual outcomes and patient satisfaction of patients who were bilaterally implanted with the Tecnis Synergy IOL between June 1 and December 31, 2021 in 2 centers in USA
What is the current status of trial NCT05418153?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2022-03-14. Estimated completion is 2022-11-22.
What conditions does trial NCT05418153 study?
This clinical trial studies the following conditions: Presbyopia, Pseudophakia.
What interventions are being tested in trial NCT05418153?
The interventions under investigation include: Tecnis Synergy IOL (DEVICE).
Who is sponsoring clinical trial NCT05418153?
This trial is sponsored by Center For Sight, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05418153 being conducted?
This trial has 2 study locations across Florida, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Comfort and Vision With TOTAL30 Multifocal Lenses
RECRUITING
-
North American Comfilcon A Clinical Study
RECRUITING
-
IC-8 Apthera IOL New Enrollment Post Approval Study
RECRUITING
-
Quality of Life in Presbyopic Patients Who Are Treated With Qlosi
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.